Multiomics Services Market to Grow with a CAGR of 17.39% through 2030
Growing
investments in omics-based drug discovery and the adoption of advanced
bioinformatics tools for data analysis, is expected to
drive the Global Multiomics Services Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Multiomics Services Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the
Global Multiomics Services Market stood at USD 1.16 Billion in 2024 and is expected to reach USD
3.04 Billion by 2030 with a CAGR of 17.39% during the forecast period. The
Global Multiomics Services Market is advancing rapidly as the demand for
comprehensive biological analysis continues to rise across clinical research,
biotechnology, and pharmaceutical applications. Multiomics integrates multiple
omics layers such as genomics, proteomics, transcriptomics, and metabolomics,
offering a deeper understanding of disease pathways and cellular functions.
This integrated approach supports the development of novel diagnostics,
personalized therapies, and improved patient care strategies. The market is
also benefiting from the increasing focus on complex diseases such as cancer,
neurological disorders, and metabolic syndromes, where single-omics approaches
fall short in providing complete insights. With rising investments in advanced
life sciences research and the growing importance of systems biology,
multiomics services are becoming a critical component of modern healthcare innovation.
Several factors
are fueling the market’s expansion, including the surge in large-scale
biomedical projects, the integration of high-throughput technologies, and the
application of machine learning in biological data analysis. Pharmaceutical
companies are relying on multiomics to enhance clinical trial design and
accelerate drug repurposing initiatives. The trend toward data-driven
healthcare is also encouraging healthcare providers to incorporate omics-driven
insights for improved diagnosis and treatment planning. Government funding and
research collaborations are further enabling infrastructure development and
access to cutting-edge technologies. The growing emphasis on real-world data
integration and population health studies is also widening the scope of
multiomics services, creating a stronger foundation for personalized healthcare
solutions.
Despite these
obstacles, the Global Multiomics Services Market is poised for strong growth
opportunities. Increasing adoption of precision oncology and immunology
research is expected to create high demand for multiomics-based platforms that
can decode tumor heterogeneity and immune responses. The emergence of
single-cell multiomics and spatial transcriptomics is opening new possibilities
for understanding tissue-specific and cell-specific disease mechanisms. Cloud
computing and AI-driven platforms are making it easier to manage and analyze
complex datasets, lowering barriers for smaller research organizations.
Expanding collaborations between technology providers, pharmaceutical
companies, and academic institutions are expected to enhance innovation pipelines.
With healthcare moving toward predictive, preventive, and personalized models,
multiomics services will play a pivotal role in shaping the next generation of
diagnostics and therapeutics.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Multiomics Services Market”
The Global Multiomics
Services Market is segmented into service, type, application, end user, regional
distribution, and company.
Based on the Application,
Synthetic Biology emerged as the fastest growing segment in the Global Multiomics
Services Market during the forecast period. This is due
to its ability to integrate genomics, transcriptomics, proteomics, and
metabolomics for engineering biological systems. Multiomics approaches enable
researchers to gain a holistic understanding of cellular mechanisms, allowing
precise design, optimization, and modification of organisms for industrial,
pharmaceutical, and environmental applications. The demand for bio-based
materials, renewable energy solutions, and engineered microorganisms for
sustainable production has accelerated the adoption of multiomics-driven
synthetic biology. By providing detailed molecular insights, multiomics
supports the development of novel genetic circuits and pathways that enhance
efficiency and reduce development timelines.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Multiomics Services Market during
the forecast period. The market’s expansion in Asia-Pacific is further
supported by the rising demand for cost-effective services, as local providers
are offering competitive pricing compared to Western counterparts, attracting
both regional and international clients. The increasing prevalence of chronic
diseases and rare disorders has prompted greater adoption of multiomics
approaches in clinical research, particularly for early diagnosis and targeted
treatment strategies. Pharmaceutical and biotechnology companies are partnering
with contract research organizations (CROs) in the region to advance biomarker
discovery and accelerate clinical trials. Strong progress in artificial
intelligence and data analytics within Asia-Pacific is also enabling faster
interpretation of complex multiomics datasets, supporting the development of
innovative solutions in synthetic biology, regenerative medicine, and
agricultural biotechnology.
Major
companies operating in Global Multiomics Services Market are:
- Sapient
Bioanalytics, LLC
- Bio-Techne
Corporation
- CD
Genomics, Inc.
- RayBiotech,
Inc.
- Creative
Proteomics, Inc.
- Psomagen,
Inc.
- Source
BioScience Ltd.
- Persistent
Systems Ltd.
- Metware
Biotechnology Inc.
- Dalton
Bioanalytics, Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Multiomics Services Market is
expanding due to the increasing emphasis on precision nutrition and
personalized lifestyle interventions, where multiomics data is being leveraged
to understand individual metabolic responses and tailor diet or wellness
strategies accordingly. This growing application beyond traditional healthcare
into preventive and consumer-driven health management is opening new avenues
for service providers, research collaborations, and commercial adoption,
thereby significantly strengthening market growth.,” said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Multiomics Services
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented By Service (Research Services, Data Analysis Services), By Type
(Single-cell Multiomics, Bulk Multiomics), By Application (Biomarker Discovery,
Drug Discovery & Development, Synthetic Biology, Others), By End User
(Academic & Research Institutes, Pharmaceutical and Biotechnology
Companies, Others), By Region and Competition, 2020-2030F”,
has evaluated the future growth potential of Global Multiomics Services Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Multiomics Services Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com